Quantcast
Last updated on April 19, 2014 at 8:29 EDT

Latest abdominal aortic aneurysm Stories

2011-01-04 15:00:00

IRVINE, Calif., Jan. 4, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. 29th Annual J.P. Morgan Event: Healthcare Conference Date: Wednesday, January 12, 2011 Time: 4:30 p.m. PT An audio Web cast of the Company's...

2010-12-20 08:00:00

IRVINE, Calif., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Guido Neels, Managing Director at Essex Woodlands Health Ventures, has joined the Endologix Board of Directors. Essex Woodlands was the majority shareholder of Nellix Inc, which was acquired by Endologix in an all stock transaction on December 13, 2010. In conjunction with the acquisition, Essex Woodlands made a $15...

2010-12-13 08:00:00

IRVINE, Calif., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement...

2010-11-29 11:46:00

IRVINE, Calif., Nov. 29, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first presentation will be at the 22nd Annual Piper Jaffray Health Care Conference in New York. Event: 22nd Annual Piper Jaffray Health Care Conference Date: Tuesday, November...

2010-11-12 08:00:00

IRVINE, Calif., Nov. 12, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that a podium presentation on the Company's Ventana(TM) fenestrated stent graft will be given at the VEITHsymposium 2010 in New York by Daniel G. Clair, MD, Chairman, Cleveland Clinic Department of Vascular Surgery, Cleveland, OH, and co-chair of the VEITHsymposium. Dr. Clair participated in the first implant of the Ventana...

2010-11-02 08:15:00

IRVINE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana(TM) fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand. The procedure was performed by Andrew Holden, MD (Associate Professor and Director of Interventional Radiology) and Andrew, Hill, MD (Associate Professor of Surgery). Attending the procedure...

2010-10-27 15:01:00

IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs). Under the terms of the agreement, Endologix will acquire Nellix for $15 million in stock at closing, plus additional...

2010-10-25 08:00:00

IRVINE, Calif., Oct. 25 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the Oppenheimer 21st Annual Healthcare Conference in New York, NY. Event: Oppenheimer's 21st Annual Healthcare Conference Date: Tuesday, November 2, 2010 Time: 12:00 p.m. ET An audio Web cast of the...

2010-10-18 15:15:00

IRVINE, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2010 financial results, which will take place on Wednesday, October 27, 2010 after the close of the market. Endologix will hold a conference call on Wednesday, October 27, 2010 at 5:30 p.m. ET / 2:30 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for...

2010-10-18 15:01:00

IRVINE, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today the publication of results from its pivotal, multicenter, prospective clinical trial of the Company's Powerlink® System for endovascular repair of abdominal aortic aneurysm (AAA) using an anatomical fixation technique with a suprarenal aortic extension. The trial demonstrated 100% procedural technical success,...